XML 42 R28.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Data
12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Segment Data
19.
Segment Data

We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Our chief operating decision maker (“CODM”) allocates resources to achieve our operating profit goals through three operating segments. These operating segments, which also constitute our reportable segments, are Americas; EMEA; and Asia Pacific.

Our CODM evaluates performance based upon segment operating profit exclusive of operating expenses and income pertaining to certain inventory and manufacturing-related charges, intangible asset amortization, goodwill and intangible asset impairment, restructuring and other cost reduction initiatives, quality remediation, acquisition, integration, divestiture and related, litigation, certain European Union Medical Device Regulation expenses, certain

research and development expenses, other charges and corporate functions (collectively referred to as “Corporate items”). Corporate functions include corporate legal, finance, information technology, human resources and other corporate departments as well as stock-based compensation and certain operations, distribution, quality assurance and regulatory expenses. Intercompany transactions have been eliminated from segment operating profit.

Our Americas operating segment is comprised principally of the U.S. and includes other North, Central and South American markets. This segment also includes research, development engineering, medical education, and brand management for our product category headquarter locations. Our EMEA operating segment is comprised principally of Europe and includes the Middle East and African markets. Our Asia Pacific operating segment is comprised principally of Japan, China and Australia and includes other Asian and Pacific markets. The EMEA and Asia Pacific operating segments include the commercial operations as well as regional headquarter expenses to operate in those markets. Since the Americas segment includes additional costs related to centralized product category headquarter expenses, profitability metrics in this operating segment are not comparable to the EMEA and Asia Pacific operating segments.

Our CODM does not review asset information by operating segment. Instead, our CODM reviews cash flow and other financial ratios by operating segment.

Net sales and other information by segment are as follows (in millions):

 

 

 

Net Sales

 

 

Operating Profit (Loss)

 

 

Depreciation and Amortization

 

 

 

Year Ended December 31,

 

 

Year Ended December 31,

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

 

2022

 

 

2021

 

 

2020

 

 

2022

 

 

2021

 

 

2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Americas

 

$

4,295.5

 

 

$

4,102.1

 

 

$

3,699.5

 

 

$

1,811.9

 

 

$

1,709.3

 

 

$

1,528.2

 

 

$

142.1

 

 

$

143.1

 

 

$

135.6

 

EMEA

 

 

1,456.6

 

 

 

1,477.2

 

 

 

1,237.3

 

 

 

380.8

 

 

 

380.3

 

 

 

303.0

 

 

 

64.4

 

 

 

71.4

 

 

 

73.9

 

Asia Pacific

 

 

1,187.8

 

 

 

1,248.0

 

 

 

1,190.7

 

 

 

407.0

 

 

 

401.3

 

 

 

395.4

 

 

 

63.5

 

 

 

66.7

 

 

 

63.0

 

Total

 

$

6,939.9

 

 

$

6,827.3

 

 

$

6,127.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate items

 

 

 

 

 

 

 

 

 

 

 

(1,083.8

)

 

 

(1,084.8

)

 

 

(1,128.4

)

 

 

129.6

 

 

 

127.0

 

 

 

113.8

 

Intangible asset amortization

 

 

 

 

 

 

 

 

 

 

 

(526.8

)

 

 

(529.5

)

 

 

(512.1

)

 

 

526.8

 

 

 

529.5

 

 

 

512.1

 

Goodwill and intangible asset impairment

 

 

 

 

 

 

 

 

 

 

 

(292.8

)

 

 

(16.3

)

 

 

(503.0

)

 

 

-

 

 

 

-

 

 

 

-

 

Total

 

 

 

 

 

 

 

 

 

 

$

696.3

 

 

$

860.3

 

 

$

83.1

 

 

$

926.4

 

 

$

937.7

 

 

$

898.4

 

We conduct business in the following countries that hold 10 percent or more of our total consolidated Property, plant and equipment, net (in millions):

 

 

 

As of December 31,

 

 

 

2022

 

 

2021

 

United States

 

$

1,101.8

 

 

$

1,084.2

 

Other countries

 

 

770.7

 

 

 

752.4

 

Property, plant and equipment, net

 

$

1,872.5

 

 

$

1,836.6

 

 

U.S. sales were $4,012.4 million, $3,853.9 million, and $3,507.7 million for the years ended December 31, 2022, 2021 and 2020, respectively. Sales within any other individual country were less than 10 percent of our consolidated sales in each of those years. Sales are attributable to a country based upon the customer's country of domicile.